title: Vaginal PGE2 and intraamniotic PGF2 alpha for the termination of second trimester pregnancy.
authors.forename: G
authors.initials: G
authors.lastname: Farmakides
authors.forename: H
authors.initials: H
authors.lastname: Schulman
authors.forename: A
authors.initials: A
authors.lastname: Fayemi
authors.forename: A
authors.initials: A
authors.lastname: Fleischer
authors.forename: J
authors.initials: J
authors.lastname: Mitchell
authors.forename: P
authors.initials: P
authors.lastname: Blattner
mesh_terms: D000028:Abortion, Induced; D000282:Administration, Intravaginal; D000650:Amnion; D015237:Dinoprost; D015232:Dinoprostone; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007267:Injections; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011458:Prostaglandins E; D011460:Prostaglandins F
chemical_list: D011458:Prostaglandins E; D011460:Prostaglandins F; D015237:Dinoprost; D015232:Dinoprostone